Suicide rates in mania with depressive symptoms

Electronic

Among the broad range of posters on display – in electronic format at IRPB for the first time – was an interesting study examining suicidality in bipolar I patients who are manic with episodes of concurrent depressive symptoms.

The poster, presented by Emmanuelle Weiller and Jonas Eberhard. was a naturalistic study: an online patient self-assessments of adult patients with bipolar I disorder, collated by 184 psychiatrists from eight countries. Of the 1035 patients who took part, 348 met the DSM-5 criteria for ‘mixed features specifier’ (≥3 depressive symptoms) during their most recent manic episode.

 

The importance of anxiety, irritability and agitation

 

Of the 48% of patients who met the criteria of severe anxiety, irritability and agitation (a score ≥4 on a 7-point scale) significantly more patients in this group had a risk of suicide vs. those with mild anxiety, irritability and agitation (no scores or one symptom with a score ≥4). Suicidal ideation was also significantly more frequent in the severe anxiety, irritability and agitation group vs. those in the mild group (72% vs. 48%; p<0.0001). The study helps highlight the added risk of suicide posed by this subgroup of bipolar I patients.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country